Global Artificial Heart Lung Machines Market Overview:
Artificial Heart-Lung Machine, also known as cardiopulmonary bypass pump, is a device used in open-heart surgery to support the body during the surgical procedure while the heart is stopped. The heart-lung machine is often referred to as the pump and does the work for both the heart (i.e., pumps blood) and the lung operation. Thhe factors such as Increased Prevalence of Heart Diseases among People, Increasing Awareness about Healthy Lifestyle and Growth in the Healthcare Infrastructure in Developing Countries are driving the global artificial heart lung machines market.
Attributes | Details |
---|
Study Period | 2018-2028 |
Base Year | 2022 |
Forecast Period | 2023-2028 |
Historical Period | 2018-2022 |
Unit | Value (USD Million) |
Customization Scope | Avail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility |
Influencing Trend:
Robust Increase in the Distribution Channels and Increasing Number of Hospitals and Clinics
Market Growth Drivers:
Increased Prevalence of Heart Diseases among People, Increasing Awareness about Healthy Lifestyle and Growth in the Healthcare Infrastructure in Developing Countries
Challenges:
Stringent Government Rules and Regulations
Restraints:
Dearth of Skilled Workforce
Opportunities:
Increasing Number of Geriatric Population, Rise in the Government Funding for Research and Development Activities and Increasing Demand from End-users
Competitive Landscape:
The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations.
Some of the key players profiled in the report are Medtronic Inc. (Ireland), Sorin Group (Italy), MAQUET GmbH & Co. KG (Germany), Terumo Corporation (Japan), C. R. Bard Inc. (United States), Edwards Lifesciences (United States), Braile Biomedica (Brazil), SynCardia Systems, LLC (United States), LivaNova PLC (Spain) and Getinge (Sweden). Additionally, following companies can also be profiled that are part of our coverage like Medtronic plc (Ireland) and Braile Biomedica (Brazil). Analyst at AMA Research see United States Players to retain maximum share of Global Artificial Heart Lung Machines market by 2028. Considering Market by End-users, the sub-segment i.e. Hospitals will boost the Artificial Heart Lung Machines market. Considering Market by Distribution Channel, the sub-segment i.e. Online Channel will boost the Artificial Heart Lung Machines market.
Latest Market Insights:
In November 2020, Medtronic plc., the global leader in medical technology completed its friendly tender offer for France-based Medicrea International. ALMED Medicrea is a pioneer in the transformation of spinal surgery through artificial intelligence (AI), predictive modeling, and patient-specific implants. Medtronic owns in excess of 90% of Medicare's share capital and voting rights and implemented a squeeze-out procedure under French law, which results in Medicrea becoming a wholly-owned subsidiary of Medtronic
In November 2019, Terumo Corporation has announced that it has decided to acquire Aortica Corporation, a U.S.-based company dedicated to advancing the science of personalized vascular therapy. Aortica has developed an automated case planning software known as AortaFit, designed to precisely match fenestrations on an endograft with the unique locations of each individual patient's branch arteries during Fenestrated Endovascular Aortic Repair (FEVAR).
What Can be Explored with the Artificial Heart Lung Machines Market Study
Gain Market Understanding
Identify Growth Opportunities
Analyze and Measure the Global Artificial Heart Lung Machines Market by Identifying Investment across various Industry Verticals
Understand the Trends that will drive Future Changes in Artificial Heart Lung Machines
Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Artificial Heart Lung Machines market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Artificial Heart Lung Machines market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Artificial Heart Lung Machines Manufacturers, Raw Material Suppliers, Distributors, Emerging Companies, Research Professionals and End-users.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.